ISSN: 2574-187X
Authors: Mitra M*
Nanomedicine is the branch of medical applications in nanotechnology. Nanomedicine ranges from medical applications of nanomaterials, biological devices to nanoelectronic biosensors, molecular nanotechnology such as biological machines. It utilizes knowledge and tools of nanotechnology to prevention and treatment of disease. Nanomedicine involves use of nanoscale materials such as biocompatible nanoparticles for delivery, sensing or actuation in a living organism. COX inhibitors are a class of pharmaceutical compounds that selectively target and inhibit the activity of the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). These enzymes are key players in the synthesis of prostaglandins, which are important mediators of inflammation, pain, and fever in the body. By modulating prostaglandin production, COX inhibitors have significant therapeutic implications in the management of various inflammatory conditions, pain relief, and fever reduction. COX-1 is constitutively expressed in many tissues and is involved in maintaining normal physiological functions, including the protection of the stomach lining and platelet aggregation. In contrast, COX-2 is induced at sites of inflammation and is primarily responsible for producing prostaglandins involved in the inflammatory response. The selective inhibition of COX-2 allows for targeted suppression of inflammation while preserving the beneficial functions of COX-1. Moreover, recent research has shed light on the complex interplay between COX-1 and COX-2 in health and disease. Emerging evidence suggests that the balance between COX-1 and COX-2 inhibition may have implications beyond pain and inflammation. Investigating the diverse roles of these enzymes in different tissues and pathologies may open up new avenues for drug development and personalized medicine. COX inhibitors represent an important therapeutic class with a profound impact on managing pain, inflammation, and related disorders. Understanding the differential regulation and functions of COX-1 and COX-2 is crucial for optimizing the clinical use of COX inhibitors and developing novel strategies for targeted and safer anti-inflammatory therapies.
Keywords: Nanomedicine; Nanotechnology; Nanomaterials; Drug Design
